What Users Say About Reimbursable Digital Therapeutics in Germany: Large-Scale App Store Review Analysis Using a Large Language Model
Abstract Background In 2019, Germany introduced a unique regulatory framework for digital therapeutics (DTx), termed digital health applications (DiGAs) in Germany, with the goal of integrating evidence-based DTx into statutory health care. DTx are eligible for reimbursement by statutory health insurance if manufacture...
Benjamin Kinast, Henrik Rohde, Björn Schreiweis et al.
· JMIR Human Factors · 0 citations